Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07824843 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety Study of GMDTC Injection in Participants With Solid Tumors and Cisplatin-Induced Renal Dysfunction

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This trial is a multicenter, combined hydration, multiple-dose, dose-escalation phase Ib clinical study, designed to evaluate the safety, tolerability, pharmacokinetic and pharmacodynamic characteristics of the injection product GMDTC in participants with solid tumors and cisplatin-induced mild renal impairment.
Trial Details
NCT Number NCT07824843
Lead Sponsor Guangdong Jianersheng Pharmaceutical Technology Co., Ltd.
Collaborators: Sun Yat-Sen University Cancer Center
Conditions
(from sponsor)		 Cisplatin Nephrotoxicity, Cisplatin Adverse Reaction
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov